Mumbai, Maharashtra, India GST : 27AABFL3068L1Z3 Verified Supplier
Leading Manufacturer, Supplier & Retailer of Imovax Polio Vaccine, Typhim Vi Typhoid Vaccine, Priorix MMR Vaccine, Fluarix Bird Swine Flu Vaccine and Pneumovax 23 Pneumo 23 Vaccine.
Typhim Vi., Typhoid Vi Polysaccharide Vaccine, produced by Sanofi Pasteur SA, for intramuscular use, is a sterile solution containing the cell surface Vi polysaccharide extracted from Salmonella enterica serovar Typhi, S typhi Ty2 strain. The organism is grown in a semisynthetic medium
Fluarix is a brand of influenza virus vaccine (injectable). Influenza virus (commonly known as "the flu") is a serious disease caused by a virus. Influenza virus can spread from one person to another through small droplets of saliva that are expelled into the air when an infected person coughs or sneezes. The virus can also be passed through contact with objects the infected person has touched, such as a door handle or other surfaces.
Pneumovax®23 (pneumococcal vaccine polyvalent) is a vaccine indicated for active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine (1, 2, 3, 4, 5, 6b, 7f, 8, 9n, 9v, 10a, 11a, 12f, 14, 15b, 17f, 18c, 19f, 19a, 20, 22f, 23f, and 33f). pneumovax 23 is approved for use in persons 50 years of age or older and persons aged ≥2 years who are at increased risk for pneumococcal disease. Pneumovax 23 will not prevent disease caused by capsular types of pneumococcus other than those contained in the vaccine
Human papilloma virus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus. Available vaccines protect against either two, four, or nine types of HPV. All vaccines protect against at least HPV type 16 and 18 that cause the greatest risk of cervical cancer.
RABIPUR® is an inactivated rabies virus vaccine, derived from the fixed-virus strain, Flury LEP. The virus is propagated in a Purified Chick Embryo Cell (PCEC) culture, inactivated using β-propiolactone and purified via centrifugation. It is supplied in a single-dose presentation consisting of a vial containing lyophilised powder (vaccine component), accompanied by an ampoule of diluent (Water for Injections
Twinrix is a vaccine against hepatitis A and hepatitis B, manufactured by GlaxoSmithKline. Twinrix is administered over three doses. The name was created because it is a mixture of two earlier vaccines — Havrix, an inactivated-virus Hepatitis A vaccine, and Engerix-B, a recombinant Hepatitis B vaccine. Twinrix, Havrix and Engerix-B are registered trademarks of GlaxoSmithKline
Description rotarix (rotavirus vaccine, live, oral), for oral administration, is a live, attenuated rotavirus vaccine derived from the human 89-12 strain which belongs to g1p type. The rotavirus strain is propagated on vero cells. After reconstitution, the final formulation (1 ml) contains at least 1060 median cell culture infective dose (ccid50) of live, attenuated rotavirus.
Cervarix is a vaccine against certain types of cancer-causing human papillomavirus (hpv). Cervarix is designed to prevent infection from hpv types 16 and 18, that cause about 70% of cervical cancer cases. these types also cause most hpv-induced genital and head and neck cancers. Additionally, some cross-reactive protection against virus strains 45 and 31 were shown in clinical trials. cervarix also contains as04, a proprietary adjuvant that has been found to boost the immune system response for a longer period of time
Hepatitis A vaccine is a vaccine that prevents hepatitis A. It is effective in around 95% of cases and lasts for at least fifteen years and possibly a person's entire life. If given, two doses are recommended beginning after the age of one. It is given by injection into a muscle. The World Health Organization (WHO) recommends universal vaccination in areas where the diseases is moderately common. Where the disease is very common, widespread vaccination is not recommended as all people typically develop immunity through infection when a child. The Center for Disease Control and Prevention (CDC) recommends vaccinating adults who are at high risk and all children.
Cholera vaccines are vaccines that are effective at preventing cholera. for the first six months after vaccination they provide about 85 percent protection, which decreases to 50 percent or 62 percent during the first year. after two years the level of protection decreases to less than 50 percent.[.
Varilrix is a lyophilised preparation of the live attenuated oka strain of varicella-zoster virus, obtained by propagation of the virus in mrc5 human diploid cell culture. Each 0.5ml dose of the reconstituted vaccine contains not less than 103.3 plaque-forming units (pfu) of the varicella-zoster virus
Menactra vaccine is indicated for active immunization to prevent invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, y, and w-135. Menactra vaccine is approved for use in individuals 9 months through 55 years of age. Menactra vaccine does not prevent n meningitidis serogroup b disease.